Free Trial

Xperi (XPER) Financials

Xperi logo
$5.32 -0.11 (-2.03%)
Closing price 10/30/2026 03:59 PM Eastern
Extended Trading
$5.34 +0.01 (+0.28%)
As of 10/30/2026 04:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Xperi

Annual Income Statements for Xperi

This table shows Xperi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-138 -176 -757 -137 -14 -56
Consolidated Net Income / (Loss)
-141 -179 -761 -140 -0.87 -56
Net Income / (Loss) Continuing Operations
-141 -179 -761 -140 -0.87 -56
Total Pre-Tax Income
-151 -160 -748 -130 12 -41
Total Operating Income
-153 -162 -749 -130 -87 -44
Total Gross Profit
298 361 379 403 380 321
Total Revenue
376 486 502 521 494 448
Operating Revenue
376 486 502 521 494 448
Total Cost of Revenue
78 126 123 119 114 127
Operating Cost of Revenue
78 126 123 119 114 127
Total Operating Expenses
451 523 1,129 532 467 365
Selling, General & Admin Expense
173 200 217 233 218 182
Research & Development Expense
163 195 216 223 191 135
Depreciation Expense
17 23 21 17 13 13
Amortization Expense
98 105 62 58 43 35
Impairment Charge
0.00 0.00 612 1.71 1.54 0.00
Total Other Income / (Expense), net
1.54 1.59 1.82 -0.01 99 3.11
Interest Expense
- - 1.51 3.00 3.01 2.98
Interest & Investment Income
- - 3.33 2.99 0.83 6.09
Other Income / (Expense), net
1.54 1.59 0.00 0.00 101 0.00
Income Tax Expense
-9.74 19 14 10 12 16
Net Income / (Loss) Attributable to Noncontrolling Interest
-2.97 -3.46 -3.72 -3.08 13 0.00
Basic Earnings per Share
($3.29) ($4.18) ($18.02) ($3.18) ($0.31) ($1.23)
Weighted Average Basic Shares Outstanding
42.02M 42.02M 42.03M 43.01M 45.06M 45.87M
Diluted Earnings per Share
($3.29) ($4.18) ($18.02) ($3.18) ($0.31) ($1.23)
Weighted Average Diluted Shares Outstanding
42.02M 42.02M 42.03M 43.01M 45.06M 45.87M
Weighted Average Basic & Diluted Shares Outstanding
- - 42.08M 44.27M 44.39M 46.97M

Quarterly Income Statements for Xperi

This table shows Xperi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-25 -13 -30 -17 46 -18 -15 -6.11 -17 -7.83 -1.50
Consolidated Net Income / (Loss)
-25 -13 -31 -20 63 -18 -15 -6.11 -17 -7.83 -1.50
Net Income / (Loss) Continuing Operations
-25 -13 -31 -20 63 -18 -15 -6.11 -17 -7.83 -1.50
Total Pre-Tax Income
-30 -9.10 -21 -17 59 -15 -10 -1.30 -14 2.29 3.33
Total Operating Income
-30 -32 -22 -19 -14 -16 -11 -1.36 -15 2.15 2.91
Total Gross Profit
104 89 91 105 95 84 72 83 82 83 78
Total Revenue
137 119 120 133 122 114 106 112 117 114 114
Operating Revenue
137 119 120 133 122 114 106 112 117 114 114
Total Cost of Revenue
34 30 29 27 28 30 34 29 34 31 36
Operating Cost of Revenue
34 30 29 27 28 30 34 29 34 31 36
Total Operating Expenses
133 121 113 124 109 101 84 84 97 81 76
Selling, General & Admin Expense
60 56 53 56 52 49 41 43 49 42 41
Research & Development Expense
56 50 45 54 42 40 30 30 36 27 22
Depreciation Expense
4.10 3.58 3.28 2.92 2.86 2.91 3.45 3.47 3.60 4.26 3.95
Amortization Expense
13 11 11 11 10 9.72 9.14 7.99 7.99 8.04 8.09
Impairment Charge
0.61 0.00 - - 1.54 0.00 0.00 - - 0.00 0.20
Total Other Income / (Expense), net
0.05 23 0.54 1.62 73 1.56 0.99 0.06 0.50 0.14 0.41
Interest Expense
0.17 0.75 0.75 0.76 0.76 0.73 0.76 0.76 0.73 0.68 0.68
Interest & Investment Income
- 1.04 1.29 2.38 - 2.30 1.75 0.82 1.23 0.82 1.10
Income Tax Expense
-4.44 4.27 9.27 2.90 -3.99 3.49 4.64 4.81 2.79 10 4.83
Basic Earnings per Share
($0.56) ($0.29) ($0.67) ($0.37) $1.02 ($0.41) ($0.32) ($0.13) ($0.37) ($0.17) ($0.03)
Weighted Average Basic Shares Outstanding
43.01M 44.52M 45.33M 45.68M 45.06M 44.77M 45.85M 46.28M 45.87M 47.35M 48.42M
Diluted Earnings per Share
($0.56) ($0.29) ($0.67) ($0.37) $1.02 ($0.41) ($0.32) ($0.13) ($0.37) ($0.17) ($0.03)
Weighted Average Diluted Shares Outstanding
43.01M 44.52M 45.33M 45.68M 45.06M 44.77M 45.85M 46.28M 45.87M 47.35M 48.42M
Weighted Average Basic & Diluted Shares Outstanding
44.27M 45.15M 45.81M 44.83M 44.39M 45.69M 46.26M 46.34M 46.97M 48.27M 48.77M

Annual Cash Flow Statements for Xperi

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
38 35 39 -5.69 -24 -34
Net Cash From Operating Activities
-24 -23 -28 0.06 -55 -0.52
Net Cash From Continuing Operating Activities
-24 -23 -28 0.06 -55 -0.52
Net Income / (Loss) Continuing Operations
-141 -179 -761 -140 -0.87 -56
Consolidated Net Income / (Loss)
-141 -179 -761 -140 -0.87 -56
Depreciation Expense
17 23 21 17 13 13
Amortization Expense
98 105 62 58 43 35
Non-Cash Adjustments To Reconcile Net Income
29 49 645 52 -83 19
Changes in Operating Assets and Liabilities, net
-26 -21 4.94 13 -27 -11
Net Cash From Investing Activities
27 -21 -65 -13 51 -21
Net Cash From Continuing Investing Activities
27 -21 -65 -13 51 -21
Purchase of Property, Plant & Equipment
-6.60 -8.89 -14 -13 -17 -21
Acquisitions
33 -13 -51 -0.19 -0.20 -0.01
Divestitures
- - 0.00 0.00 68 0.00
Net Cash From Financing Activities
34 83 136 7.05 -19 -12
Net Cash From Continuing Financing Activities
34 83 136 7.05 -19 -12
Repayment of Debt
- - - 0.00 0.00 -52
Repurchase of Common Equity
- - 0.00 0.00 -20 0.00
Issuance of Debt
- - - 0.00 0.00 41
Issuance of Common Equity
- 0.00 0.00 12 7.86 5.97
Other Financing Activities, net
34 83 136 -4.88 -7.22 -6.97
Effect of Exchange Rate Changes
1.37 -3.33 -3.03 0.13 0.00 0.00
Cash Interest Paid
0.00 0.00 0.76 3.00 3.01 2.42
Cash Income Taxes Paid
8.58 12 13 21 19 13

Quarterly Cash Flow Statements for Xperi

This table details how cash moves in and out of Xperi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
23 -59 -2.74 -20 58 -43 7.16 1.64 0.04 -26 20
Net Cash From Operating Activities
21 -50 -2.13 -4.65 1.23 -22 10 7.54 4.10 -18 15
Net Cash From Continuing Operating Activities
21 -50 -2.13 -4.65 1.23 -22 10 7.54 4.10 -18 15
Net Income / (Loss) Continuing Operations
-25 -13 -31 -20 63 -18 -15 -6.11 -17 -7.83 -1.50
Consolidated Net Income / (Loss)
-25 -13 -31 -20 63 -18 -15 -6.11 -17 -7.83 -1.50
Depreciation Expense
4.10 3.58 3.28 2.92 2.86 2.91 3.45 3.47 3.60 4.26 3.95
Amortization Expense
13 11 11 11 10 9.72 9.14 7.99 7.99 8.04 8.09
Non-Cash Adjustments To Reconcile Net Income
13 -13 -2.40 -6.24 -62 3.77 12 0.62 2.10 -11 1.58
Changes in Operating Assets and Liabilities, net
16 -38 17 7.57 -13 -20 0.02 1.56 7.50 -12 2.44
Net Cash From Investing Activities
-3.35 -4.71 -3.73 -4.42 64 -4.21 -4.78 -5.62 -6.38 -4.83 -6.95
Net Cash From Continuing Investing Activities
-3.35 -4.71 -3.73 -4.42 64 -4.21 -4.78 -5.62 -6.38 -4.83 -6.95
Purchase of Property, Plant & Equipment
-3.32 -4.45 -3.68 -4.35 -4.28 -4.19 -4.79 -5.62 -6.38 -4.83 -6.92
Acquisitions
-0.04 -0.27 -0.05 -0.07 0.19 -0.01 0.01 - - 0.00 -0.02
Net Cash From Financing Activities
5.52 -4.67 3.07 -11 -7.03 -16 1.83 -0.28 2.32 -3.55 13
Net Cash From Continuing Financing Activities
5.52 -4.67 3.07 -11 -7.03 -16 1.83 -0.28 2.32 -3.55 13
Other Financing Activities, net
-0.56 -4.67 -1.26 -0.72 -0.57 -5.29 -1.06 -0.28 -0.34 -3.55 10
Cash Interest Paid
0.76 0.76 0.75 0.75 0.76 0.48 0.66 0.66 0.63 0.58 0.59
Cash Income Taxes Paid
5.83 4.24 4.97 3.05 6.87 2.42 1.80 3.08 5.72 2.20 1.99

Annual Balance Sheets for Xperi

This table presents Xperi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
1,229 737 674 668 616
Total Current Assets
277 332 317 305 267
Cash & Equivalents
121 160 142 131 97
Note & Lease Receivable
- - - - 0.00
Accounts Receivable
130 130 120 142 135
Prepaid Expenses
- 42 39 32 24
Other Current Assets
26 - - 0.00 12
Plant, Property, & Equipment, net
57 48 42 44 52
Total Noncurrent Assets
894 357 315 318 296
Noncurrent Note & Lease Receivables
3.83 4.29 0.00 30 32
Goodwill
537 - - - 0.00
Intangible Assets
271 264 207 164 129
Noncurrent Deferred & Refundable Income Taxes
1.85 2.10 5.09 7.23 5.28
Other Noncurrent Operating Assets
81 86 91 118 130
Other Noncurrent Nonoperating Assets
- 0.00 12 - 0.00
Total Liabilities & Shareholders' Equity
1,229 737 674 668 616
Total Liabilities
213 288 287 239 202
Total Current Liabilities
120 150 165 185 111
Short-Term Debt
- - 0.00 50 0.00
Accounts Payable
7.36 15 21 17 12
Accrued Expenses
84 110 110 94 82
Current Deferred Revenue
28 25 28 24 16
Other Current Nonoperating Liabilities
- 0.00 6.19 - 0.00
Total Noncurrent Liabilities
93 138 121 53 91
Long-Term Debt
0.00 50 50 0.00 40
Noncurrent Deferred Revenue
24 19 19 21 15
Noncurrent Deferred & Payable Income Tax Liabilities
14 13 6.98 1.49 1.43
Other Noncurrent Operating Liabilities
55 56 35 31 35
Other Noncurrent Nonoperating Liabilities
- 0.00 9.81 - 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,016 449 387 429 414
Total Preferred & Common Equity
1,025 463 404 0.00 414
Preferred Stock
0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,025 463 404 429 414
Common Stock
0.00 1,136 1,213 1,275 1,314
Retained Earnings
0.00 -669 -805 -839 -896
Accumulated Other Comprehensive Income / (Loss)
-0.68 -4.12 -2.87 -6.08 -4.44

Quarterly Balance Sheets for Xperi

This table presents Xperi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
687 671 664 630 619 616 633 629 629 607 616
Total Current Assets
297 288 296 272 266 259 267 284 273 261 284
Cash & Equivalents
111 112 132 95 92 73 88 95 97 70 91
Note & Lease Receivable
- - - - - - - - - - 12
Accounts Receivable
140 136 125 134 138 147 142 141 135 150 154
Prepaid Expenses
- 40 39 43 36 38 37 36 30 29 27
Other Current Assets
47 - - - - - - 12 12 12 0.00
Plant, Property, & Equipment, net
47 46 45 42 42 44 46 47 50 51 55
Total Noncurrent Assets
343 337 324 317 311 314 321 299 305 295 277
Noncurrent Note & Lease Receivables
9.56 17 22 44 29 29 82 31 31 32 21
Goodwill
- - - - - - - - - - 3.33
Intangible Assets
250 235 220 196 185 174 154 145 137 121 113
Noncurrent Deferred & Refundable Income Taxes
2.28 2.40 2.47 4.89 4.95 5.06 7.33 7.73 7.83 6.59 4.97
Other Noncurrent Operating Assets
81 82 79 72 92 105 78 115 129 135 135
Other Noncurrent Nonoperating Assets
- - - 0.00 0.00 0.17 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity
687 671 664 630 619 616 633 629 629 607 616
Total Liabilities
257 257 278 249 249 260 215 209 208 199 201
Total Current Liabilities
126 127 151 130 133 201 118 113 113 110 114
Short-Term Debt
- - - - - 50 0.00 0.00 0.00 0.00 0.00
Accounts Payable
14 11 16 20 14 19 15 15 17 13 17
Accrued Expenses
87 91 110 84 90 106 79 78 78 82 82
Current Deferred Revenue
25 25 26 26 28 26 24 20 18 15 15
Other Current Nonoperating Liabilities
- - - 0.00 0.00 0.07 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Liabilities
131 130 126 119 117 59 97 96 95 89 87
Long-Term Debt
50 50 50 50 50 0.00 40 40 40 40 40
Noncurrent Deferred Revenue
19 18 19 23 22 20 19 18 17 14 12
Noncurrent Deferred & Payable Income Tax Liabilities
13 12 12 7.01 7.00 7.02 1.49 1.49 1.49 1.43 1.43
Other Noncurrent Operating Liabilities
49 49 45 39 37 32 36 37 37 33 34
Other Noncurrent Nonoperating Liabilities
- - - 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
431 414 386 382 370 356 419 420 421 408 415
Total Preferred & Common Equity
446 431 403 399 389 377 0.00 420 421 0.00 415
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
446 431 403 399 389 377 419 420 421 408 415
Common Stock
1,149 1,173 1,189 1,222 1,242 1,256 1,281 1,294 1,303 1,318 1,327
Retained Earnings
-701 -739 -781 -819 -849 -876 -858 -873 -879 -904 -905
Accumulated Other Comprehensive Income / (Loss)
-2.64 -3.17 -5.49 -4.04 -4.38 -3.34 -3.89 -1.59 -3.63 -6.27 -6.47

Annual Metrics And Ratios for Xperi

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - -
Revenue Growth
0.00% 29.35% 3.24% 3.80% -5.30% -9.23%
EBITDA Growth
0.00% 10.54% -1,961.41% 91.71% 226.31% -93.50%
EBIT Growth
0.00% -6.10% -367.70% 82.70% 110.61% -417.86%
NOPAT Growth
0.00% -6.07% -363.10% 82.70% 107.20% -568.43%
Net Income Growth
0.00% -26.74% -325.07% 81.65% 99.38% -6,383.20%
EPS Growth
0.00% -27.05% -331.10% 82.35% 90.25% -296.77%
Operating Cash Flow Growth
0.00% 1.36% -21.29% 100.22% -89,358.06% 99.07%
Free Cash Flow Firm Growth
0.00% 0.00% 103.15% -209.51% -69.54% 33.35%
Invested Capital Growth
0.00% 0.00% -62.15% -16.50% 23.18% 2.51%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.33% -2.92% -1.29%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 82.69% 510.71% -94.64%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 67.33% 117.80% -226.11%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 67.50% 109.10% 2.47%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 66.13% 99.03% -337.62%
EPS Q/Q Growth
0.00% 0.00% 0.00% 67.15% 83.60% -868.75%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 100.16% -54.12% 84.79%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 40.13% 38.43%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -7.21% 5.06% -1.92%
Profitability Metrics
- - - - - -
Gross Margin
79.32% 74.18% 75.52% 77.25% 76.96% 71.74%
EBITDA Margin
-9.61% -6.65% -132.74% -10.60% 14.13% 1.01%
Operating Margin
-40.56% -33.26% -149.21% -24.87% -17.64% -9.76%
EBIT Margin
-40.16% -32.94% -149.21% -24.87% 2.79% -9.76%
Profit (Net Income) Margin
-37.57% -36.81% -151.56% -26.79% -0.18% -12.57%
Tax Burden Percent
93.55% 111.76% 101.82% 107.75% -7.51% 138.71%
Interest Burden Percent
100.00% 100.00% 99.76% 100.01% 84.16% 92.88%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 107.51% 0.00%
Return on Invested Capital (ROIC)
0.00% -25.31% -85.02% -29.19% 2.07% -8.67%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 83.73% 119.99% 16.48% 10.08% 28.78%
Return on Net Nonoperating Assets (RNNOA)
0.00% -9.95% -18.91% -4.23% -2.28% -4.69%
Return on Equity (ROE)
0.00% -35.25% -103.92% -33.41% -0.21% -13.36%
Cash Return on Invested Capital (CROIC)
0.00% -225.31% 5.15% -11.20% -18.70% -11.15%
Operating Return on Assets (OROA)
0.00% -13.04% -76.25% -18.38% 2.05% -6.81%
Return on Assets (ROA)
0.00% -14.57% -77.45% -19.81% -0.13% -8.78%
Return on Common Equity (ROCE)
0.00% -35.57% -105.60% -34.67% -0.22% -13.36%
Return on Equity Simple (ROE_SIMPLE)
0.00% -17.47% -164.26% -34.56% -0.20% 0.00%
Net Operating Profit after Tax (NOPAT)
-107 -113 -525 -91 6.53 -31
NOPAT Margin
-28.40% -23.29% -104.45% -17.41% 1.32% -6.83%
Net Nonoperating Expense Percent (NNEP)
0.00% -109.03% -205.01% -45.67% -8.01% -37.45%
Return On Investment Capital (ROIC_SIMPLE)
- - -105.13% -20.76% 1.36% -6.74%
Cost of Revenue to Revenue
20.68% 25.82% 24.48% 22.75% 23.04% 28.26%
SG&A Expenses to Revenue
45.89% 41.10% 43.28% 44.77% 44.18% 40.59%
R&D to Revenue
43.45% 40.06% 43.08% 42.74% 38.76% 30.14%
Operating Expenses to Revenue
119.88% 107.44% 224.73% 102.11% 94.60% 81.50%
Earnings before Interest and Taxes (EBIT)
-151 -160 -749 -130 14 -44
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-36 -32 -667 -55 70 4.53
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.78 1.15 1.01 0.59
Price to Tangible Book Value (P/TBV)
0.00 0.00 1.82 2.35 1.63 0.86
Price to Revenue (P/Rev)
0.00 0.00 0.72 0.89 0.87 0.55
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
2.41% 1.12% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.70 1.25 1.01 0.53
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.47 0.68 0.71 0.42
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 5.03 41.78
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 25.51 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 53.71 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 5,708.36 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 7.46 0.00 0.00 0.00
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 0.11 0.13 0.12 0.10
Long-Term Debt to Equity
0.00 0.00 0.11 0.13 0.00 0.10
Financial Leverage
0.00 -0.12 -0.16 -0.26 -0.23 -0.16
Leverage Ratio
0.00 1.21 1.34 1.69 1.64 1.52
Compound Leverage Factor
0.00 1.21 1.34 1.69 1.38 1.41
Debt to Total Capital
0.00% 0.00% 10.02% 11.44% 10.44% 8.81%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 10.44% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 10.02% 11.44% 0.00% 8.81%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% -0.91% -2.89% -3.91% 0.00% 0.00%
Common Equity to Total Capital
0.00% 100.91% 92.87% 92.47% 89.56% 91.19%
Debt to EBITDA
0.00 0.00 -0.08 -0.91 0.72 8.82
Net Debt to EBITDA
0.00 0.00 0.17 1.67 -1.15 -12.53
Long-Term Debt to EBITDA
0.00 0.00 -0.08 -0.91 0.00 8.82
Debt to NOPAT
0.00 0.00 -0.10 -0.55 7.65 -1.31
Net Debt to NOPAT
0.00 0.00 0.21 1.01 -12.33 1.86
Long-Term Debt to NOPAT
0.00 0.00 -0.10 -0.55 0.00 -1.31
Altman Z-Score
0.00 0.00 -2.89 -0.29 0.35 -0.51
Noncontrolling Interest Sharing Ratio
0.00% -0.91% -1.61% -3.77% -2.09% 0.00%
Liquidity Ratios
- - - - - -
Current Ratio
0.00 2.31 2.21 1.92 1.64 2.42
Quick Ratio
0.00 2.09 1.93 1.59 1.47 2.10
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -1,009 32 -35 -59 -39
Operating Cash Flow to CapEx
-360.20% -263.72% -200.22% 0.49% -330.23% -2.46%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 21.03 -11.61 -19.63 -13.21
Operating Cash Flow to Interest Expense
0.00 0.00 -18.81 0.02 -18.40 -0.17
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 -28.21 -4.23 -23.97 -7.21
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.40 0.51 0.74 0.74 0.70
Accounts Receivable Turnover
0.00 3.73 3.86 4.17 3.77 3.24
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 8.46 9.54 11.66 11.48 9.30
Accounts Payable Turnover
0.00 17.06 11.06 6.64 6.01 8.64
Days Sales Outstanding (DSO)
0.00 97.88 94.63 87.54 96.82 112.81
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 21.39 32.99 54.94 60.69 42.27
Cash Conversion Cycle (CCC)
0.00 76.49 61.63 32.60 36.13 70.54
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 895 339 283 349 357
Invested Capital Turnover
0.00 1.09 0.81 1.68 1.56 1.27
Increase / (Decrease) in Invested Capital
0.00 895 -556 -56 66 8.74
Enterprise Value (EV)
0.00 0.00 237 354 351 189
Market Capitalization
0.00 0.00 362 463 432 246
Book Value per Share
$0.00 $24.39 $11.03 $9.30 $9.57 $8.94
Tangible Book Value per Share
$0.00 $5.18 $4.74 $4.54 $5.92 $6.16
Total Capital
0.00 1,016 499 437 479 454
Total Debt
0.00 0.00 50 50 50 40
Total Long-Term Debt
0.00 0.00 50 50 0.00 40
Net Debt
0.00 -121 -110 -92 -81 -57
Capital Expenditures (CapEx)
6.60 8.89 14 13 17 21
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 36 22 9.72 39 60
Debt-free Net Working Capital (DFNWC)
0.00 157 182 152 170 157
Net Working Capital (NWC)
0.00 157 182 152 120 157
Net Nonoperating Expense (NNE)
34 66 237 49 7.40 26
Net Nonoperating Obligations (NNO)
0.00 -121 -110 -104 -81 -57
Total Depreciation and Amortization (D&A)
115 128 83 74 56 48
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 7.50% 4.36% 1.86% 7.89% 13.39%
Debt-free Net Working Capital to Revenue
0.00% 32.31% 36.24% 29.12% 34.34% 35.00%
Net Working Capital to Revenue
0.00% 32.31% 36.24% 29.12% 24.21% 35.00%
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($18.02) ($3.18) ($0.31) ($1.23)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 42.03M 43.01M 45.06M 45.87M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($18.02) ($3.18) ($0.31) ($1.23)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 42.03M 43.01M 45.06M 45.87M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 42.08M 44.27M 44.39M 46.97M
Normalized Net Operating Profit after Tax (NOPAT)
-107 -113 -96 -90 -60 -31
Normalized NOPAT Margin
-28.40% -23.29% -19.12% -17.18% -12.13% -6.83%
Pre Tax Income Margin
-40.16% -32.94% -148.85% -24.87% 2.35% -9.06%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
0.00 0.00 -495.66 -43.21 4.57 -14.68
NOPAT to Interest Expense
0.00 0.00 -346.96 -30.25 2.17 -10.28
EBIT Less CapEx to Interest Expense
0.00 0.00 -505.05 -47.46 -1.00 -21.72
NOPAT Less CapEx to Interest Expense
0.00 0.00 -356.36 -34.50 -3.40 -17.32
Payout Ratios
- - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -2,300.35% 0.00%

Quarterly Metrics And Ratios for Xperi

This table displays calculated financial ratios and metrics derived from Xperi's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
- - - - - 44,388,930.00 45,687,072.00 46,260,160.00 - 46,969,801.00 48,271,456.00
DEI Adjusted Shares Outstanding
- - - - - 44,388,930.00 45,687,072.00 46,260,160.00 - 46,969,801.00 48,271,456.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - -0.41 -0.32 -0.13 - -0.17 -0.03
Growth Metrics
- - - - - - - - - - -
Revenue Growth
1.26% -6.30% -5.74% 1.92% -10.84% -4.05% -11.42% -16.00% -4.79% 0.15% 8.08%
EBITDA Growth
95.58% 135.62% 53.11% 80.76% 705.41% -172.91% 119.23% 314.65% -104.17% 479.12% 925.09%
EBIT Growth
90.02% 72.05% 37.73% 47.91% 305.46% -75.02% 49.18% 92.66% -123.26% 113.08% 126.17%
NOPAT Growth
90.03% 3.79% 37.73% 40.24% 26.89% 49.14% 49.18% 92.66% 32.09% 36.18% 83.14%
Net Income Growth
91.51% 59.41% 22.19% 52.86% 348.74% -37.36% 51.75% 69.20% -127.13% 57.39% 89.85%
EPS Growth
92.07% 61.84% 25.56% 61.46% 282.14% -41.38% 52.24% 64.86% -136.27% 58.54% 90.63%
Operating Cash Flow Growth
220.74% -15.51% -39.84% -119.34% -94.05% 55.29% 573.62% 262.13% 233.60% 19.06% 44.06%
Free Cash Flow Firm Growth
0.00% 102.72% 102.47% 87.82% -330.54% -528.47% -581.62% 15.89% 76.38% 69.45% 97.48%
Invested Capital Growth
-16.50% -9.01% -7.00% 8.79% 23.18% 10.21% 11.32% 9.80% 2.51% 1.80% -0.05%
Revenue Q/Q Growth
5.25% -13.40% 0.63% 11.12% -7.92% -6.81% -7.10% 5.38% 4.37% -1.98% 0.25%
EBITDA Q/Q Growth
-1.81% 142.70% -245.07% 69.37% 3,303.66% -104.96% 138.26% 591.91% -131.77% 550.76% 3.46%
EBIT Q/Q Growth
4.02% 68.43% -133.23% 26.16% 478.55% -125.84% 32.28% 87.77% -986.34% 114.54% 35.43%
NOPAT Q/Q Growth
4.02% -8.47% 32.23% 15.30% -17.43% 24.55% 32.28% 87.77% -986.34% 29.09% 82.11%
Net Income Q/Q Growth
39.83% 47.18% -129.09% 35.26% 417.50% -129.17% 19.52% 58.68% -179.76% 54.19% 80.83%
EPS Q/Q Growth
41.67% 48.21% -131.03% 44.78% 375.68% -140.20% 21.95% 59.38% -184.62% 54.05% 82.35%
Operating Cash Flow Q/Q Growth
-14.02% -340.97% 95.71% -117.81% 126.44% -1,911.07% 145.41% -25.44% -45.59% -539.39% 180.82%
Free Cash Flow Firm Q/Q Growth
110.73% -69.46% -12.99% -527.13% -103.10% 43.24% 2.20% 25.40% 42.96% 26.59% 91.93%
Invested Capital Q/Q Growth
-7.21% 18.95% -2.66% 1.26% 5.06% 6.43% -1.68% -0.12% -1.92% 5.69% -3.47%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
75.54% 74.96% 75.79% 79.32% 77.47% 74.04% 68.33% 73.95% 70.46% 72.96% 68.50%
EBITDA Margin
-8.96% 4.40% -6.34% -1.75% 60.85% -3.34% 1.38% 9.04% -2.75% 12.66% 13.06%
Operating Margin
-21.72% -27.20% -18.32% -13.96% -11.68% -14.42% -10.51% -1.22% -12.70% 1.88% 2.54%
EBIT Margin
-21.72% -7.90% -18.32% -12.17% 50.04% -14.42% -10.51% -1.22% -12.70% 1.88% 2.54%
Profit (Net Income) Margin
-18.45% -11.25% -25.61% -14.92% 51.46% -16.11% -13.95% -5.47% -14.66% -6.85% -1.31%
Tax Burden Percent
85.08% 146.95% 143.37% 117.12% 106.76% 123.45% 145.70% 469.05% 119.53% -341.45% -45.10%
Interest Burden Percent
99.83% 96.87% 97.53% 104.67% 96.31% 90.49% 91.13% 95.59% 96.60% 106.56% 114.18%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% -6.76% 0.00% 0.00% 0.00% 0.00% 441.45% 145.10%
Return on Invested Capital (ROIC)
-25.49% -27.67% -19.09% -15.61% -19.49% -13.95% -10.10% -1.11% -11.29% -7.70% -1.44%
ROIC Less NNEP Spread (ROIC-NNEP)
-21.34% -45.16% 10.15% -2.66% -104.16% 0.77% 4.22% 11.63% -1.49% -6.48% -1.09%
Return on Net Nonoperating Assets (RNNOA)
5.47% 5.89% -1.35% 0.38% 23.58% -0.09% -0.52% -1.21% 0.24% 0.61% 0.14%
Return on Equity (ROE)
-20.02% -21.79% -20.44% -15.24% 4.09% -14.04% -10.62% -2.32% -11.05% -7.09% -1.30%
Cash Return on Invested Capital (CROIC)
-11.20% -16.00% -16.45% -30.98% -18.70% 10.63% -20.95% -18.36% -11.15% -6.49% -2.08%
Operating Return on Assets (OROA)
-16.05% -6.16% -14.37% -9.67% 36.84% -11.15% -8.00% -0.89% -8.87% 1.36% 1.87%
Return on Assets (ROA)
-13.63% -8.77% -20.09% -11.85% 37.88% -12.46% -10.62% -3.99% -10.24% -4.95% -0.96%
Return on Common Equity (ROCE)
-20.78% -22.66% -21.35% -16.02% 4.17% -14.34% -10.87% -2.39% -11.05% -7.09% -1.30%
Return on Equity Simple (ROE_SIMPLE)
0.00% -30.09% -28.65% -23.62% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-21 -23 -15 -13 -15 -12 -7.79 -0.95 -10 -7.34 -1.31
NOPAT Margin
-15.20% -19.04% -12.82% -9.77% -12.46% -10.09% -7.36% -0.85% -8.89% -6.43% -1.15%
Net Nonoperating Expense Percent (NNEP)
-4.15% 17.48% -29.24% -12.96% 84.67% -14.72% -14.32% -12.74% -9.79% -1.23% -0.35%
Return On Investment Capital (ROIC_SIMPLE)
-4.77% - - - -3.18% -2.51% -1.69% -0.21% -2.28% -1.64% -0.29%
Cost of Revenue to Revenue
24.46% 25.04% 24.21% 20.68% 22.53% 25.96% 31.67% 26.05% 29.55% 27.04% 31.50%
SG&A Expenses to Revenue
43.36% 47.42% 44.40% 42.50% 42.63% 42.71% 38.84% 38.10% 42.48% 36.59% 36.21%
R&D to Revenue
40.69% 42.44% 37.73% 40.35% 34.46% 34.68% 28.11% 26.81% 30.73% 23.71% 19.05%
Operating Expenses to Revenue
97.26% 102.16% 94.11% 93.28% 89.15% 88.46% 78.84% 75.17% 83.15% 71.08% 65.95%
Earnings before Interest and Taxes (EBIT)
-30 -9.39 -22 -16 61 -16 -11 -1.36 -15 2.15 2.91
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-12 5.23 -7.59 -2.32 74 -3.81 1.46 10 -3.21 14 15
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.15 1.27 0.89 1.03 1.01 0.77 0.79 0.65 0.59 0.58 0.83
Price to Tangible Book Value (P/TBV)
2.35 2.49 1.69 1.91 1.63 1.22 1.21 0.96 0.86 0.82 1.16
Price to Revenue (P/Rev)
0.89 0.99 0.68 0.76 0.87 0.66 0.70 0.60 0.55 0.53 0.76
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 39.11 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.56% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.25 1.32 0.87 1.04 1.01 0.75 0.76 0.59 0.53 0.54 0.81
Enterprise Value to Revenue (EV/Rev)
0.68 0.87 0.56 0.68 0.71 0.57 0.58 0.47 0.42 0.46 0.65
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 5.03 4.55 3.97 2.55 41.78 8.99 8.13
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 25.51 41.19 15.86 6.22 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 53.71 3.84 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
5,708.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 54.97 36.09
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 7.35 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.13 0.13 0.14 0.14 0.12 0.10 0.10 0.10 0.10 0.10 0.10
Long-Term Debt to Equity
0.13 0.13 0.14 0.00 0.00 0.10 0.10 0.10 0.10 0.10 0.10
Financial Leverage
-0.26 -0.13 -0.13 -0.14 -0.23 -0.12 -0.12 -0.10 -0.16 -0.09 -0.13
Leverage Ratio
1.69 1.62 1.64 1.73 1.64 1.58 1.58 1.60 1.52 1.50 1.49
Compound Leverage Factor
1.68 1.57 1.60 1.81 1.58 1.43 1.44 1.53 1.47 1.60 1.70
Debt to Total Capital
11.44% 11.58% 11.90% 12.32% 10.44% 8.72% 8.70% 8.68% 8.81% 8.93% 8.79%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 12.32% 10.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
11.44% 11.58% 11.90% 0.00% 0.00% 8.72% 8.70% 8.68% 8.81% 8.93% 8.79%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
-3.91% -4.03% -4.44% -5.32% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
92.47% 92.45% 92.54% 93.00% 89.56% 91.28% 91.30% 91.32% 91.19% 91.07% 91.21%
Debt to EBITDA
-0.91 -1.41 -1.87 -2.94 0.72 0.66 0.57 0.47 8.82 1.75 1.10
Net Debt to EBITDA
1.67 1.28 1.59 1.34 -1.15 -0.79 -0.79 -0.67 -12.53 -1.33 -1.39
Long-Term Debt to EBITDA
-0.91 -1.41 -1.87 0.00 0.00 0.66 0.57 0.47 8.82 1.75 1.10
Debt to NOPAT
-0.55 -0.56 -0.62 -0.70 7.65 0.56 -1.13 -1.27 -1.31 -2.27 -5.15
Net Debt to NOPAT
1.01 0.50 0.53 0.32 -12.33 -0.67 1.56 1.81 1.86 1.73 6.51
Long-Term Debt to NOPAT
-0.55 -0.56 -0.62 0.00 0.00 0.56 -1.13 -1.27 -1.31 -2.27 -5.15
Altman Z-Score
0.19 0.44 -0.13 -0.24 0.58 -0.02 0.03 -0.15 -0.35 -0.33 0.06
Noncontrolling Interest Sharing Ratio
-3.77% -4.03% -4.46% -5.16% -2.09% -2.17% -2.36% -2.78% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.92 2.10 2.01 1.29 1.64 2.27 2.50 2.42 2.42 2.36 2.48
Quick Ratio
1.59 1.77 1.74 1.09 1.47 1.95 2.08 2.05 2.10 2.00 2.25
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
35 11 9.32 -40 -81 -46 -45 -33 -19 -14 -1.13
Operating Cash Flow to CapEx
623.07% -1,119.31% -57.93% -106.92% 28.72% -530.84% 211.18% 134.07% 64.29% -372.67% 210.28%
Free Cash Flow to Firm to Interest Expense
201.49 14.32 12.46 -52.64 -106.92 -62.68 -59.12 -43.99 -26.27 -20.67 -1.65
Operating Cash Flow to Interest Expense
118.74 -66.56 -2.85 -6.15 1.63 -30.41 13.32 9.90 5.64 -26.57 21.29
Operating Cash Flow Less CapEx to Interest Expense
99.68 -72.51 -7.78 -11.90 -4.03 -36.14 7.01 2.52 -3.13 -33.70 11.16
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.74 0.78 0.78 0.79 0.74 0.77 0.76 0.73 0.70 0.72 0.73
Accounts Receivable Turnover
4.17 3.75 3.70 3.73 3.77 3.54 3.41 3.22 3.24 3.07 3.09
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
11.66 11.56 11.42 11.54 11.48 11.19 10.66 9.66 9.30 9.23 8.97
Accounts Payable Turnover
6.64 7.21 9.21 6.87 6.01 6.63 8.08 6.58 8.64 9.43 8.18
Days Sales Outstanding (DSO)
87.54 97.35 98.63 97.78 96.82 103.08 107.01 113.43 112.81 118.84 117.98
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
54.94 50.64 39.65 53.16 60.69 55.02 45.19 55.46 42.27 38.73 44.63
Cash Conversion Cycle (CCC)
32.60 46.71 58.98 44.63 36.13 48.06 61.83 57.97 70.54 80.12 73.35
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
283 337 328 332 349 371 365 364 357 378 364
Invested Capital Turnover
1.68 1.45 1.49 1.60 1.56 1.38 1.37 1.30 1.27 1.20 1.25
Increase / (Decrease) in Invested Capital
-56 -33 -25 27 66 34 37 33 8.74 6.67 -0.18
Enterprise Value (EV)
354 444 284 344 351 276 277 216 189 205 295
Market Capitalization
463 507 345 388 432 324 332 272 246 235 346
Book Value per Share
$9.30 $9.02 $8.61 $8.24 $9.57 $9.44 $9.19 $9.10 $8.94 $8.69 $8.60
Tangible Book Value per Share
$4.54 $4.59 $4.51 $4.44 $5.92 $5.97 $6.02 $6.14 $6.16 $6.11 $6.19
Total Capital
437 432 420 406 479 459 460 461 454 448 455
Total Debt
50 50 50 50 50 40 40 40 40 40 40
Total Long-Term Debt
50 50 50 0.00 0.00 40 40 40 40 40 40
Net Debt
-92 -45 -42 -23 -81 -48 -55 -57 -57 -30 -51
Capital Expenditures (CapEx)
3.32 4.45 3.68 4.35 4.28 4.19 4.79 5.62 6.38 4.83 6.92
Debt-free, Cash-free Net Working Capital (DFCFNWC)
9.72 47 41 35 39 61 75 63 60 80 79
Debt-free Net Working Capital (DFNWC)
152 143 134 108 170 149 170 160 157 151 169
Net Working Capital (NWC)
152 143 134 58 120 149 170 160 157 151 169
Net Nonoperating Expense (NNE)
4.45 -9.26 15 6.84 -78 6.86 6.99 5.15 6.73 0.48 0.19
Net Nonoperating Obligations (NNO)
-104 -45 -42 -24 -81 -48 -55 -57 -57 -30 -51
Total Depreciation and Amortization (D&A)
18 15 14 14 13 13 13 11 12 12 12
Debt-free, Cash-free Net Working Capital to Revenue
1.86% 9.23% 8.18% 6.85% 7.89% 12.47% 15.80% 13.93% 13.39% 17.87% 17.25%
Debt-free Net Working Capital to Revenue
29.12% 27.78% 26.46% 21.14% 34.34% 30.47% 35.82% 35.25% 35.00% 33.58% 37.08%
Net Working Capital to Revenue
29.12% 27.78% 26.46% 11.31% 24.21% 30.47% 35.82% 35.25% 35.00% 33.58% 37.08%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.56) ($0.29) ($0.67) ($0.37) $1.02 ($0.41) ($0.32) ($0.13) ($0.37) ($0.17) ($0.03)
Adjusted Weighted Average Basic Shares Outstanding
43.01M 44.52M 45.33M 45.68M 45.06M 44.77M 45.85M 46.28M 45.87M 47.35M 48.42M
Adjusted Diluted Earnings per Share
($0.56) ($0.29) ($0.67) ($0.37) $1.02 ($0.41) ($0.32) ($0.13) ($0.37) ($0.17) ($0.03)
Adjusted Weighted Average Diluted Shares Outstanding
43.01M 44.52M 45.33M 45.68M 45.06M 44.77M 45.85M 46.28M 45.87M 47.35M 48.42M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
44.27M 45.15M 45.81M 44.83M 44.39M 45.69M 46.26M 46.34M 46.97M 48.27M 48.77M
Normalized Net Operating Profit after Tax (NOPAT)
-20 -23 -15 -13 -8.93 -12 -7.79 -0.95 -10 1.51 2.18
Normalized NOPAT Margin
-14.89% -19.04% -12.82% -9.77% -7.29% -10.09% -7.36% -0.85% -8.89% 1.32% 1.90%
Pre Tax Income Margin
-21.68% -7.66% -17.87% -12.74% 48.20% -13.05% -9.58% -1.17% -12.27% 2.01% 2.91%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-171.28 -12.56 -29.29 -21.40 81.00 -22.46 -14.67 -1.79 -20.35 3.17 4.26
NOPAT to Interest Expense
-119.90 -30.25 -20.50 -17.18 -20.18 -15.72 -10.27 -1.25 -14.25 -10.83 -1.92
EBIT Less CapEx to Interest Expense
-190.34 -18.50 -34.21 -27.15 75.34 -28.19 -20.97 -9.18 -29.12 -3.96 -5.86
NOPAT Less CapEx to Interest Expense
-138.95 -36.20 -25.43 -22.93 -25.84 -21.45 -16.57 -8.64 -23.02 -17.96 -12.04
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% -2,300.35% 0.00% 0.00% 42.14% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Xperi’s second-quarter 2026 results show meaningful sequential improvement, although the company has not yet returned to consistent profitability. Revenue was $114.5 million, up 8.1% from $105.9 million in the second quarter of 2025 but below the $119.6 million reported in the second quarter of 2024 and $126.9 million in the second quarter of 2023. Gross profit increased to $78.4 million, producing a gross margin of approximately 68.5%.

Operating performance improved considerably. Xperi generated $2.9 million of operating income in Q2 2026, compared with operating losses of $11.1 million in Q2 2025 and $21.9 million in Q2 2024. Net loss narrowed to $1.5 million, or $0.03 per share, from a $14.8 million loss, or $0.32 per share, in the year-ago quarter. However, the improvement was not entirely reflected in earnings quality because depreciation and amortization totaled approximately $12.0 million during the quarter.

Cash flow also improved sharply from the first quarter. Operating cash flow was $14.6 million in Q2 2026, compared with negative operating cash flow of $18.0 million in Q1 2026. After $6.9 million of capital expenditures, the company produced roughly $7.6 million of operating free cash flow before financing effects. Cash increased to $90.6 million, but the $20.2 million quarterly increase was heavily supported by $12.6 million of financing inflows, including $10.4 million classified as other financing activities.

  • Improved profitability: Xperi moved from an $11.1 million operating loss in Q2 2025 to $2.9 million of operating income in Q2 2026, while the net loss narrowed by approximately 90% year over year.
  • Stronger operating cash flow: Q2 operating cash flow of $14.6 million was the strongest result in the supplied 2025–2026 quarterly data and more than offset quarterly capital expenditures.
  • Revenue recovery: Revenue grew 8.1% year over year to $114.5 million, reversing part of the decline seen from 2023 through 2025.
  • Solid near-term liquidity: Xperi held $90.6 million of cash and had $283.6 million of current assets against $114.2 million of current liabilities, implying a current ratio of approximately 2.5.
  • Manageable reported debt: The company had no short-term debt and $40.0 million of long-term debt, leaving cash well above reported borrowings.
  • Cash generation remains uneven: Operating cash flow was negative in Q1 2026 but positive in Q2, indicating that working-capital movements and noncash adjustments continue to create significant quarter-to-quarter volatility.
  • Revenue remains below earlier levels: Despite the latest rebound, Q2 2026 revenue was still approximately 9.7% below Q2 2023 revenue of $126.9 million.
  • Receivables are substantial: Accounts receivable rose to $154.2 million, representing more than half of current assets. Investors should monitor collections and customer payment trends.
  • Persistent cumulative losses: Retained earnings remained deeply negative at approximately $905.1 million, reflecting the company’s long history of losses despite recent operating improvement.
  • Shareholder dilution and financing dependence: Weighted-average basic shares increased to 48.4 million from 46.2 million in Q2 2025, while the large financing inflow was an important contributor to the quarterly cash increase.

Overall, the latest statements point to a potentially important turnaround in operating execution: revenue has stabilized, operating income has turned positive, and operating cash flow has recovered. Still, investors should treat the improvement cautiously because profitability is modest, cash flow has been volatile, intangible assets and other noncurrent operating assets represent a large portion of the balance sheet, and share dilution appears to be continuing.

11/01/26 08:26 PM ETAI Generated. May Contain Errors.

Xperi Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Xperi's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Xperi's net income appears to be on an upward trend, with a most recent value of -$56.34 million in 2025, rising from -$141.29 million in 2020. The previous period was -$869 thousand in 2024. See Xperi's forecast for analyst expectations on what's next for the company.

Xperi's total operating income in 2025 was -$43.73 million, based on the following breakdown:
  • Total Gross Profit: $321.46 million
  • Total Operating Expenses: $365.19 million

Over the last 5 years, Xperi's total revenue changed from $376.10 million in 2020 to $448.11 million in 2025, a change of 19.1%.

In the past 13 quarters, Xperi's cash and equivalents has ranged from $70.42 million in Q1 2026 to $131.53 million in Q3 2023, and is currently $90.59 million as of their latest financial filing in Q2 2026.

Xperi had total debt of $40 million at the end of 2025, a 20.0% decrease from 2024, and none in 2020.

Over the last 5 years, Xperi's book value per share changed from 0.00 in 2020 to 8.94 in 2025, a change of 893.7%.



Financial statements for NYSE:XPER last updated on 8/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners